Cargando…

Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy

Platelet activating factor is a lipid mediator of inflammation, and in recent decades, it has emerged as an important factor in tumor outcomes. Platelet activating factor acts by specific binding to its receptor, which is present in both tumor cells and cells that infiltrate tumors. Pro-tumorigenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva Junior, Ildefonso Alves, Andrade, Luciana Nogueira de Sousa, Jancar, Sonia, Chammas, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157068/ https://www.ncbi.nlm.nih.gov/pubmed/30328954 http://dx.doi.org/10.6061/clinics/2018/e792s

Ejemplares similares

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy
por: da Silva-Jr, I A, et al.
Publicado: (2017)

Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death
por: da Silva-Junior, Ildefonso Alves, et al.
Publicado: (2018)

Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017)

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
por: de Oliveira, Soraya I, et al.
Publicado: (2010)

Secretory Autophagy Forges a Therapy Resistant Microenvironment in Melanoma
por: Bustos, Silvina Odete, et al.
Publicado: (2022)

Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
por: Cardoso, Ana Carolina Ferreira, et al.
Publicado: (2016)

Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
por: Saito, Renata de Freitas, et al.
Publicado: (2022)

Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications
por: Santos, Nathalia Leal, et al.
Publicado: (2021)

Impaired wound healing in type 1 diabetes is dependent on 5-lipoxygenase products
por: Ramalho, Theresa, et al.
Publicado: (2018)

Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles
por: Murillo Carrasco, Alexis Germán, et al.
Publicado: (2023)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke
por: Belayev, Ludmila, et al.
Publicado: (2011)

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012)

Boosting Adaptive Immunity: A New Role for PAFR Antagonists
por: Koga, Marianna M., et al.
Publicado: (2016)

Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma
por: Onuchic, Ana Claudia, et al.
Publicado: (2012)

Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer
por: Li, Xuanxuan, et al.
Publicado: (2021)

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
por: Cirilo, Priscila Daniele Ramos, et al.
Publicado: (2017)

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
por: Mari, Andrea, et al.
Publicado: (2017)

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer
por: Käsmann, Lukas, et al.
Publicado: (2019)

A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Lara-Velazquez, Montserrat, et al.
Publicado: (2021)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy
por: Andrade, Luciana Nogueira de Sousa, et al.
Publicado: (2019)

Planned neck dissection following chemo-radiotherapy in advanced HNSCC
por: Gupta, Tejpal, et al.
Publicado: (2004)

LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis
por: Garcia-Padilla, Carlos, et al.
Publicado: (2022)

Clearance of Apoptotic Cells by Macrophages Induces Regulatory Phenotype and Involves Stimulation of CD36 and Platelet-Activating Factor Receptor
por: Ferracini, Matheus, et al.
Publicado: (2013)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy?
por: Patel, H, et al.
Publicado: (2009)

Gender-differences of in vitro colonic motility after chemo- and radiotherapy in humans
por: Maselli, Maria Antonietta, et al.
Publicado: (2018)

On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery
por: Glimelius, Bengt
Publicado: (2017)

ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
por: Huang, Gan, et al.
Publicado: (2020)

Fertility preservation in chemo-radiotherapy for rectal cancer: A combined approach
por: Mariani, S., et al.
Publicado: (2019)

Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy
por: Herrscher, H., et al.
Publicado: (2019)

Gold Nanopeanuts as Prospective Support for Cisplatin in Glioblastoma Nano-Chemo-Radiotherapy
por: Depciuch, Joanna, et al.
Publicado: (2020)

Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
por: Liu, Ya‐Ping, et al.
Publicado: (2021)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy
por: Nickoloff, Jac A.
Publicado: (2022)

The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
por: Hassanian, Hamidreza, et al.
Publicado: (2022)

A systematic analysis on the clinical safety and efficacy of onco-virotherapy
por: Bhatt, Darshak K., et al.
Publicado: (2021)

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015)

Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor
por: Bachi, André Luis Lacerda, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8an50t7vq7iue1kk6fv00gssvs